Skip to main content

Advertisement

Log in

Atorvastatin-induced dermatomyositis

  • Cases with a Message
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

A 49-year-old man with no previous history of musculoskeletal or cutaneous problems who had a myocardial infarction (MI) was treated with atorvastatin, prasugrel, enoxaparine, and diltiazem following percutaneous coronary intervention. He was referred to our rheumatology outpatient clinic for rash and papules on the knuckles, face, and neck, as well as proximal muscle weakness. In the physical examination, a reddish rash on the face and Gottron’s papules on the knuckles were detected. The skin biopsy performed indicated interface dermatitis with hydropic degeneration of basal keratinocytes, supporting the clinical impression of dermatomyositis. He was started on prednisolone 1 mg/kg/day. After 30 days of prednisolone therapy, all symptoms disappeared.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Scandinavian Simvastatin Survival Group (1994) Randomised trial cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). The Lancet 344(8934):1383–1389

    Google Scholar 

  2. Downs JR, Clearfield M, Weis S et al (1998) Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 279:1615–1622

    Article  CAS  PubMed  Google Scholar 

  3. Sacks FM (2004) Do statins play a role in the early management of the acute coronary syndrome? Eur Heart J Suppl 6(Supplement A):A32–A36

    Article  CAS  Google Scholar 

  4. Law M, Rudnicka AR (2006) Statin safety: a systematic review. Am J Cardiol 97(8A):52C–60C

    Article  CAS  PubMed  Google Scholar 

  5. Grable-Esposito P, Katzberg HD, Greenberg SA, Srinivasan J, Katz J, Amato AA (2010) Immune-mediated necroziting myopathy associated with statins. Muscle Nerve 41(2):185–190

    CAS  PubMed  Google Scholar 

  6. Komai E, Takemoto M, Yokote K (2015) Atorvastatin-induced dermatomyositis in a 47-year-old woman with Sjögren’s syndrome. Acta Cardiol 70(3):373

    Article  PubMed  Google Scholar 

  7. Noël B, Cerottini JP, Panizzon RG (2001) Atorvastatin-induced Dermatomyositis. Am J Med 110(8):670–671

    Article  PubMed  Google Scholar 

  8. Cannon CS (2012) Statin-induced rhabdomyolysis and dermatomyositis: A rare combination. JAAPA 25(8):32–33

    Google Scholar 

  9. Noël B (2004) Statins and lupus erythematosus Rheumotology(Oxford) 43(3):pp 397–398

  10. Taylor BA, Thompson PD (2015) Muscle-related side-effects of statins: from mechanisms to evidence-based solutions. Curr Opin Lipidol 26(3):221–227

    Article  CAS  PubMed  Google Scholar 

  11. Mammen AL (2016) Statin-Associated Autoimmune Myopathy. N Engl J Med 374:664–669

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

There was no financial support for this work and none of the authors had any financial interest or any conflict of interest with regard to this work.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mert Oztas.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Oztas, M., Ugurlu, S. & Aydin, O. Atorvastatin-induced dermatomyositis. Rheumatol Int 37, 1217–1219 (2017). https://doi.org/10.1007/s00296-017-3658-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3658-9

Keywords

Navigation